Section Arrow
XENE.NASDAQ
- Xenon Pharmaceuticals
Quotes are at least 15-min delayed:2024/05/16 08:33 EDT
Last
 40.45
-0.13 (-0.32%)
Day High 
41.87 
Prev. Close
40.58 
1-M High
44.3672 
Volume 
355.42K 
Bid
35
Ask
64.72
Day Low
40.15 
Open
41.08 
1-M Low
38.6 
Market Cap 
3.06B 
Currency USD 
P/E -- 
%Yield
10-SMA 42.29 
20-SMA 41.46 
50-SMA 42.59 
52-W High 50.99 
52-W Low 27.985 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.72/-3.31
Enterprise Value
3.07B
Balance Sheet
Book Value Per Share
11.76
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8391-0.0237-2.75%-- 
NVAXNovavax12.9-0.58-4.30%-- 
JAGXJaguar Health0.2551-0.0198-7.20%-- 
OCGNOcugen1.96+0.26+15.29%-- 
ARQTArcutis Biotherapeutics9.24+1.11+13.65%-- 
Quotes are at least 15-min delayed:2024/05/16 08:33 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.